i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
-
Published Date:
Mar 2015
-
Publisher's site:
-
Source:Emerg Infect Dis. 21(3):500-503.
-
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB-positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was generally well-tolerated; further research of its efficacy against MDR TB is needed.
-
Subject:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
text/plain text/plain
No Related Documents.